Recombinant DNA Technology Market - 2021-
Description
Recombinant DNA Technology Market Overview:
The Recombinant DNA Technology Market was valued at USD 156.75 billion in 2021 and is anticipated to reach by , at a CAGR of 0.048 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Recombinant DNA Technology Market.
This report delivers a comprehensive overview of the Recombinant DNA Technology Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Recombinant DNA Technology Market. The Recombinant DNA Technology Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–.
Recombinant DNA Technology Market Scope:
Key Players
• Monsanto Company
• F. Hoffmann-La Roche Ltd
• Biogen
• Amgen Inc
• Novartis AG
• Eli Lilly and Company
• GenScript
• Pfizer Inc.
• Novo Nordisk A/S
• Sanofi
• Merck KGaA
• Profacgen
• Biocon
• GlaxoSmithKline plc.
• Cibus
• Horizon Discovery Group plc
• New England Biolabs
• Thermo Fisher Scientific, Inc.
Major Highlights
This report delivers a comprehensive overview of the Recombinant DNA Technology Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Recombinant DNA Technology Market. The Recombinant DNA Technology Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
South America (Colombia, Brazil, Argentina, Rest of South America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Partner Identification
Increase Your Customer Base by 3X using our Partner Identification tool
Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
Prioritize partners by strategic fit rather than general capability.
Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
Target Audience 2026
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
The Recombinant DNA Technology Market was valued at USD 156.75 billion in 2021 and is anticipated to reach by , at a CAGR of 0.048 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Recombinant DNA Technology Market.
This report delivers a comprehensive overview of the Recombinant DNA Technology Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Recombinant DNA Technology Market. The Recombinant DNA Technology Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–.
Recombinant DNA Technology Market Scope:
Key Players
• Monsanto Company
• F. Hoffmann-La Roche Ltd
• Biogen
• Amgen Inc
• Novartis AG
• Eli Lilly and Company
• GenScript
• Pfizer Inc.
• Novo Nordisk A/S
• Sanofi
• Merck KGaA
• Profacgen
• Biocon
• GlaxoSmithKline plc.
• Cibus
• Horizon Discovery Group plc
• New England Biolabs
• Thermo Fisher Scientific, Inc.
Major Highlights
This report delivers a comprehensive overview of the Recombinant DNA Technology Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Recombinant DNA Technology Market. The Recombinant DNA Technology Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
South America (Colombia, Brazil, Argentina, Rest of South America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Partner Identification
Increase Your Customer Base by 3X using our Partner Identification tool
Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
Prioritize partners by strategic fit rather than general capability.
Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
Target Audience 2026
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
Table of Contents
210 Pages
- 1. Methodology and Scope
- 1.1. Research Methodology
- 1.2. Research Objective and Scope of the Report
- 2. Market Definition and Overview
- 3. Executive Summary
- 3.1. Market Snippet by Product Type
- 3.2. Market Snippet by Component
- 3.3. Market Snippet by Application
- 3.4. Market Snippet by End-User
- 3.5. Market Snippet by Region
- 4. Market Dynamics
- 4.1. Market Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. Technological Advancements
- 4.1.1.2. Rising of Biopharmaceutical Industry
- 4.1.1.3. XX
- 4.1.2. Restraints:
- 4.1.2.1. Regulatory, scientific, and ethical challenges
- 4.1.2.2. The risk associated with the use of Recombinant DNA Technology
- 4.1.2.3. XX
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis
- 5. Industry Analysis
- 5.1. Porter's Five Forces Analysis
- 5.2. Epidemiology
- 5.3. Pipeline Analysis
- 5.4. Supply Chain Analysis
- 5.5. Pricing Analysis
- 5.6. Regulatory Analysis
- 5.7. Reimbursement Analysis
- 5.8. Unmet Needs
- 6. COVID-19 Analysis
- 6.1. Analysis of Covid-19 on the Market
- 6.1.1. Before COVID-19 Market Scenario
- 6.1.2. Present COVID-19 Market Scenario
- 6.1.3. After COVID-19 or a Future Scenario
- 6.2. Pricing Dynamics Amid Covid-19
- 6.3. Demand-Supply Spectrum
- 6.4. Government Initiatives Related to the Market During the Pandemic
- 6.5. Manufacturers Strategic Initiatives
- 6.6. Conclusion
- 7. By Product Type
- 7.1. Introduction
- 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
- 7.3. Market Attractiveness Index, By Product Type Segment
- 7.3.1. Medical*
- 7.3.1.1. Introduction
- 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
- 7.3.1.3. Therapeutic Agent
- 7.3.1.4. Human Protein
- 7.3.1.5. Vaccine
- 7.3.2. Non-medical
- 7.3.2.1. Biotech Crops
- 7.3.2.2. Specialty Chemicals
- 7.3.2.3. Other
- 8. By Component
- 8.1. Introduction
- 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
- 8.3. Market Attractiveness Index, By Component Segment
- 8.3.1. Expression System*
- 8.3.1.1. Introduction
- 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
- 8.3.1.3. Mammalian
- 8.3.1.4. Bacteria
- 8.3.1.5. Yeast
- 8.3.1.6. Baculovirus / Insect
- 8.3.1.7. Others
- 8.3.2. Cloning Vector
- 9. By Application
- 9.1. Introduction
- 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 9.3. Market Attractiveness Index, By Application Segment
- 9.3.1. Food and Agriculture*
- 9.3.1.1. Introduction
- 9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
- 9.3.2. Health and Disease
- 9.3.3. Environment
- 9.3.4. Others
- 10. By End-User
- 10.1. Introduction
- 10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
- 10.3. Market Attractiveness Index, By End-User Segment
- 10.3.1. Biotechnology and Pharmaceutical Companies*
- 10.3.1.1. Introduction
- 10.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
- 10.3.2. Academic and Government Research Institutes
- 10.3.3. Others
- 11. By Region
- 11.1. Introduction
- 11.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
- 11.3. Market Attractiveness Index, By Region
- 11.4. North America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
- 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
- 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 11.4.7.1. The U.S.
- 11.4.7.2. Canada
- 11.4.7.3. Mexico
- 11.5. Europe
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
- 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
- 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 11.5.7.1. Germany
- 11.5.7.2. The U.K.
- 11.5.7.3. France
- 11.5.7.4. Italy
- 11.5.7.5. Spain
- 11.5.7.6. Rest of Europe
- 11.6. South America
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
- 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
- 11.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 11.6.7.1. Brazil
- 11.6.7.2. Argentina
- 11.6.7.3. Rest of South America
- 11.7. Asia Pacific
- 11.7.1. Introduction
- 11.7.2. Key Region-Specific Dynamics
- 11.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 11.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
- 11.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 11.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
- 11.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- 11.7.7.1. China
- 11.7.7.2. India
- 11.7.7.3. Japan
- 11.7.7.4. Australia
- 11.7.7.5. Rest of Asia Pacific
- 11.8. Middle East and Africa
- 11.8.1. Introduction
- 11.8.2. Key Region-Specific Dynamics
- 11.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
- 11.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
- 11.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 11.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
- 12. Competitive Landscape
- 12.1. Competitive Scenario
- 12.2. Market Positioning/Share Analysis
- 12.3. Mergers and Acquisitions Analysis
- 13. Company Profiles
- 13.1. Monsanto Company*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Key Highlights
- 13.1.4. Financial Overview
- 13.2. F. Hoffmann-La Roche Ltd
- 13.3. Biogen
- 13.4. Amgen Inc
- 13.5. Novartis AG
- 13.6. Eli Lilly and Company
- 13.7. GenScript
- 13.8. Pfizer Inc.
- 13.9. Novo Nordisk A/S
- 13.10. Sanofi
- 13.11. Merck KGaA
- 13.12. Profacgen
- 13.13. Biocon
- 13.14. GlaxoSmithKline plc.
- 13.15. Cibus
- 13.16. Horizon Discovery Group plc
- 13.17. New England Biolabs
- 13.18. Thermo Fisher Scientific, Inc. (LIST NOT EXHAUSTIVE)
- 14. DataM Intelligence
- 14.1. Appendix
- 14.2. About Us and Services
- 14.3. Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
